LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
MALAT1 | miR-1 | cdc42 | CDC42;CDC42Hs;G25K | details
Chemokine signaling pathway;MAPK signaling pathway;Endocytosis;Axon guidance;Epithelial cell signaling in Helicobacter pylori infection;Viral carcinogenesis;Neurotrophin signaling pathway;Bacterial invasion of epithelial cells;Renal cell carcinoma;Shigellosis;Salmonella infection;Pancreatic cancer;VEGF signaling pathway;Focal adhesion;Pathways in cancer;Pathogenic Escherichia coli infection;Adherens junction;Tight junction;GnRH signaling pathway;Regulation of actin cytoskeleton;T cell receptor signaling pathway;Fc gamma R-mediated phagocytosis;Leukocyte transendothelial migration;Proteoglycans in cancer
|
details
In this study we identified long non-coding RNA (lncRNA) MALAT1 can function as a ceRNA of cell division cycle 42 (cdc42) 3'UTR in inducing migration and invasion of breast cancer cells via miR-1. We found that miR-1 bound both MALAT1 and cdc42 3'UTR directly.
|
details
MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42
|
Breast Cancer | Biochem Biophys Res Commun | 26926567 |
MALAT1 | miR-124 | CDK4 | CDK4;CMM3;PSK-J3 | details
Tight junction;Cell cycle;p53 signaling pathway;Bladder cancer;Non-small cell lung cancer;PI3K-Akt signaling pathway;T cell receptor signaling pathway;Hepatitis B;Melanoma;Glioma;Measles;HTLV-I infection;Pathways in cancer;Small cell lung cancer;Viral carcinogenesis;Pancreatic cancer;Chronic myeloid leukemia
|
details
Furthermore, MALAT1 acted as an endogenous potent regulator by directly binding to miR-124 and down-regulating miR-124 expression. In addition, MALAT1 reversed the inhibitory effect of miR-124 on breast cancer proliferation and was involved in the cyclin-dependent kinase 4 (CDK4) expression.
|
details
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation
|
Breast Cancer | Oncotarget | 26918449 |
MALAT1 | miR-124 | E2F1 | E2F1;E2F-1;RBAP1;RBBP3;RBP3 | details
HTLV-I infection;Cell cycle;Hepatitis B;Non-small cell lung cancer;Pathways in cancer;Pancreatic cancer;Glioma;Prostate cancer;Melanoma;Bladder cancer;Chronic myeloid leukemia;Small cell lung cancer
|
details
Moreover, the present study elucidated the MALAT1-miR-124-CDK4/E2F1 signaling pathway in breast cancer, which might provide a new approach for tackling breast cancer.
|
details
miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation
|
Breast Cancer | Oncotarget | 26918449 |
SNHG16 | miR-98 | E2F5 | E2F5;E2F-5 | details
Cell cycle;TGF-beta signaling pathway
|
details
Taken together, our findings indicated that SNHG16 induces breast cancer cell migration by competitively binding miR-98 with E2F5, and SNHG16 can serve as a potential therapeutic target for breast cancer treatment.
|
details
SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5
|
Breast Cancer | Biochem Biophys Res Commun | 28232182 |
NEAT1 | miR-101 | EZH2 | EZH2;ENX-1;ENX1;EZH1;EZH2b;KMT6;KMT6A;WVS;WVS2 | details | details
In our research, lncRNA-NEAT1 was specifically upregulated in BC cell lines and promoted BC cell growth through targeting miR-101. Knockdown of NEAT1 inhibited the proliferation and DNA synthesis of human BC cell in vitro. In addition, the regulation of EZH2 by miR-101 was required in NEAT1 induced BC cell growth. These findings indicated that NEAT1 might suppress the tumor growth via miR-101 dependent EZH2 regulation.
|
details
The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2
|
Breast Cancer | Arch Biochem Biophys | 28034643 |
NEAT1 | miR-101-3p | EZH2 | EZH2;ENX-1;ENX1;EZH1;EZH2b;KMT6;KMT6A;WVS;WVS2 | details | details
In our research, lncRNA-NEAT1 was specifically upregulated in BC cell lines and promoted BC cell growth through targeting miR-101. Knockdown of NEAT1 inhibited the proliferation and DNA synthesis of human BC cell in vitro. In addition, the regulation of EZH2 by miR-101 was required in NEAT1 induced BC cell growth. These findings indicated that NEAT1 might suppress the tumor growth via miR-101 dependent EZH2 regulation.
|
details
The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2
|
Breast Cancer | Arch Biochem Biophys | 28034643 |
XIAP | miR-29a-5p | FSCN1 | FSCN1;FAN1;HSN;SNL;p55 | details | details
Furthermore, we demonstrated that one miRNA, miR-29a-5p, can bind to both the XIAP and FSCN1 3'UTRs and play an important role in that interactions.
|
details
XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p
|
Breast Cancer | Oncotarget | 28186968 |
NEAT1 | miR-548 | FUS | FUS;ALS6;ETM4;FUS1;HNRNPP2;POMP75;TLS | details
Transcriptional misregulation in cancer
|
details
In addition, the RNA-binding protein fused in sarcoma/translocated in liposarcoma (FUS/TLS) physically interacted with NEAT1, and reducing the expression of FUS/TLS also induced cell apoptosis. Multiple miRNAs were identified as regulators of NEAT1, but only overexpression of miR-548ar was able to decrease NEAT1 expression and promote apoptosis.
|
details
NEAT1 is Required for Survival of Breast Cancer Cells Through FUS and miR-548
|
Breast Cancer | Gene Regul Syst Bio | 27147820 |
UCA1 | miR-18a | HIF-1alpha | HIF1A;HIF-1A;HIF-1alpha;HIF1;HIF1-ALPHA;MOP1;PASD8;bHLHe78 | details
HIF-1 signaling pathway;mTOR signaling pathway;Pathways in cancer;Proteoglycans in cancer;Renal cell carcinoma
|
details
The upregulated UCA1 sponges miR-18a, which is a negative regulator of HIF1α. Therefore, UCA1 upregulation is further enhanced through a miR-18a-HIF1α feedback loop.
|
details
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
|
Breast Cancer | Tumour Biol | 27629141 |
MALAT1 | miR-448 | KDM5B | KDM5B;CT31;JARID1B;PLU-1;PLU1;PPP1R98;PUT1;RBBP2H1A | details | details
KDM5B-silencing in the TNBC cells correlated with the upregulation of hsa-miR-448 and led to suppression of MALAT1 expression with decreased migration, invasion and clonogenic capacity in vitro, as well as, poor survival in vivo.
|
details
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
|
Breast Cancer | BMC Cancer | 26917489 |
TUG1 | miR-9 | MTHFD2 | MTHFD2;NMDMC | details
One carbon pool by folate;Metabolic pathways
|
details
TUG1 knockdown reduced proliferation, suppressed cell cycle progression, and promoted apoptosis of MCF-7 cells. The dual luciferase reporter assay showed that TUG1 could negatively regulate the expression of miR-9. MiR-9 inhibition abrogated the effect of TUG1 knockdown on the proliferation, cell cycle progression, and apoptosis of MCF-7 cells. TUG1 positively regulated the expression of MTHFD2 in breast cancer cells.
|
details
LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells
|
Breast Cancer | J Breast Cancer | 28053623 |
GAS5 | miR-21 | PTEN | PTEN;10q23del;BZS;CWS1;DEC;GLM2;MHAM;MMAC1;PTEN1;TEP1 | details
p53 signaling pathway;Inositol phosphate metabolism;Prostate cancer;Phosphatidylinositol signaling system;mTOR signaling pathway;PI3K-Akt signaling pathway;Focal adhesion;Tight junction;Hepatitis B;Pathways in cancer;Melanoma;Endometrial cancer;Glioma;Small cell lung cancer
|
details
GAS5 suppresses cancer proliferation by acting as a molecular sponge for miR-21, leading to the de-repression of phosphatase and tensin homologs (PTEN), the endogenous target of miR-21.
|
details
Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer
|
Breast Cancer | Oncotarget | 27034004 |
MALAT1 | miR-1 | slug | SNAI2;SLUG;SLUGH1;SNAIL2;WS2D | details
Hippo signaling pathway;Adherens junction
|
details
In addition, our findings demonstrate a reciprocal negative control relationship between MALAT1 and miR-1: downregulation of MALAT1 increased expression of microRNA-1 (miR-1), while overexpression of miR-1 decreased MALAT1 expression. Slug was identified as a direct target of miR-1. We proposed that MALAT1 exerted its function through the miR-1/slug axis.
|
details
Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
|
Breast Cancer | Tumour Biol | 26676637 |
HOTAIR | miR-34a | Sox2 | SOX2;ANOP3;MCOPS3 | details
Hippo signaling pathway
|
details
Moreover, full-length HOTAIR transcriptionally inhibits miR-34a specifically, leading to upregulation of Sox2, which is targeted by miR-34a.
|
details
Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells
|
Breast Cancer | PLoS One | 28122024 |
ROR | miR-205 | ZEB1 | ZEB1;AREB6;BZP;DELTAEF1;FECD6;NIL2A;PPCD3;TCF8;ZFHEP;ZFHX1A | details
Transcriptional misregulation in cancer
|
details
Compared with the MCF7 cells, the MCF7-ROR cells had remarkably higher proliferation rates, down-regulated E-cadherin and miR-205 expressions, as well as increased vimentin, invasive ability, and mRNA expression of ZEB1 and ZEB2. Compared with the MCF7/TR5 and MDA-MB-231 cells, up-regulated E-cadherin and miR-205 expression, down-regulated expression of vimentin, ZEB1, and ZEB2 mRNA, and decreased invasive ability were observed in the MCF7/TR5 ROR-siRNA and MDA-MB-231 ROR-siRNA cells.
|
details
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
|
Breast Cancer | Cancer Chemother Pharmacol | 28063065 |
ROR | miR-205 | ZEB2 | ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B | details | details
Specifically, linc-ROR prevented the degradation of mir-205 target genes, including the EMT inducer ZEB2.
|
details
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
|
Breast Cancer | Cell Death Dis | 24922071 |
ROR | miR-205 | ZEB2 | ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B | details | details
Compared with the MCF7 cells, the MCF7-ROR cells had remarkably higher proliferation rates, down-regulated E-cadherin and miR-205 expressions, as well as increased vimentin, invasive ability, and mRNA expression of ZEB1 and ZEB2. Compared with the MCF7/TR5 and MDA-MB-231 cells, up-regulated E-cadherin and miR-205 expression, down-regulated expression of vimentin, ZEB1, and ZEB2 mRNA, and decreased invasive ability were observed in the MCF7/TR5 ROR-siRNA and MDA-MB-231 ROR-siRNA cells.
|
details
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
|
Breast Cancer | Cancer Chemother Pharmacol | 28063065 |